Home › Markets › Health Care › CVKD

Cadrenal Therapeutics Inc. (CVKD)

CVKD trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$0.9970
+14.28% on the day
Market cap
$3.6M
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerCVKD on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2023
SEC CIK0001937993
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Not reported in SEC XBRL data.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS
424B32026-07-20
Latest annual report
ANNUAL REPORT
10-K2026-03-31
Latest quarterly / interim
QUARTERLY REPORT
10-Q2026-08-13
Latest current report
CURRENT REPORT
8-K2026-10-07
Latest proxy
DEFINITIVE ADDITIONAL MATERIALS
DEFA14A2026-08-03

Source: SEC EDGAR submissions feed, 277 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
SBFMSunshine Biopharma Inc.$0.2363-21.75%$3.6M
GRIGRI Bio Inc.$1.55-1.27%$3.4M
EOCNEocene Ltd.$3.17-1.71%$3.3M
CAPSCapstone Holding Corp.$0.1242-6.83%$3.3M
SXTP60 Degrees Pharmaceuticals Inc.$0.9000-1.70%$3.2M
CMNDClearmind Medicine Inc. Common Shares$6.23-4.74%$3.2M
RDHLRedhill Biopharma Ltd.$0.5150-3.45%$3.1M
APVOAptevo Therapeutics Inc.$1.73-5.79%$3.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier